XAMS
WKL
Market cap18bUSD
Sep 18, Last price
68.16EUR
1D
-2.74%
1Q
15.80%
Jan 2017
98.02%
Name
Wolters Kluwer NV
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Wolters Kluwer N.V., founded in 1836 and headquartered in Alphen aan den Rijn, the Netherlands, operates as a global provider of specialized information, software, and services. The company's extensive reach covers Europe, the United States, Canada, the Asia Pacific region, and other international markets. Its diverse offerings are organized into four primary business divisions. The Health segment delivers clinical technology and evidence-based solutions that are instrumental in fostering effective decision-making and improving patient outcomes across the healthcare spectrum. This segment serves a wide array of clients, including hospitals, various healthcare providers, individual clinicians, students, medical and nursing schools, libraries, retail pharmacies, payers, and life sciences organizations. The Tax & Accounting segment offers solutions designed to enhance productivity, facilitate adaptation to evolving conditions, and achieve superior results for tax, accounting, and audit professionals. Its customer base includes accounting firms, corporate finance, tax, and auditing departments, government bodies, libraries, and universities. The Governance, Risk & Compliance (GRC) segment provides technology-driven services and solutions that address legal entity adherence, legal operations management, banking product conformity, and regulatory reporting requirements. This division caters to legal, compliance, and risk professionals within corporations, small businesses, law firms, insurers, banks, non-bank lenders, credit unions, leasing companies, and securities firms. Finally, the Legal & Regulatory segment supplies evidence-based information, actionable insights, and integrated workflow solutions. These tools empower customers to make sound decisions, streamline compliance processes, boost productivity and performance, mitigate risks, and confidently resolve complex challenges. Its clientele comprises legal and compliance professionals, operational risk managers, and environmental, health, and safety managers in law firms, corporations, universities, and government agencies.
Related entities
Subsidiaries (56)
ACCESS MATRIX TECHNOLOGIES PRIVATE LIMITED
C T CORPORATION SYSTEM
Enablon Netherlands B.V.
PT Wolters Kluwer Financial Services Indonesia
Tagetik Austria GmbH
Tagetik Benelux B.V.
Tagetik GmbH
Tagetik Nordic AB
Tagetik Schweiz AG
TAGETIK SOFTWARE S.R.L.
UPTODATE, INC.
WOLTERS KLUWER (INDIA) PRIVATE LIMITED
WOLTERS KLUWER (IRELAND) LIMITED
WOLTERS KLUWER ELM SOLUTIONS PRIVATE LIMITED
WOLTERS KLUWER ELM SOLUTIONS, INC.
WOLTERS KLUWER HEALTH, INC.
WOLTERS KLUWER HOLDINGS (UK) LIMITED
Wolters Kluwer International Holding B.V.
Wolters Kluwer Legal Software Deutschland GmbH
Wolters Kluwer SR s.r.o.
Headquarters & legal address
Zuidpoolsingel 2
Alphen aan den Rijn, ZH 2408 ZE
NL
Alphen aan den Rijn, ZH 2408 ZE
NL
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||